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2.3 Pathogenesis and etiology of endemic goiter 
General aspects and TRH 
II. Medizinische Klinik (Direktor: Prof. Dr. med. E. Buchhorn) and 
Klinik für Radiologie (Direktor: Prof. Dr. med. J. Lissner) 
der Universität München, BRD. 
TOTAL SERUM T 3 AND TSH RESPONSE 
TO TRH STIMULATION IN 
PATIENTS WITH ENDEMIC GOITER* 
P . C. S c r i b a , H . B o r o w z a k , F . E r h a r d t , ] . Grüner, ] . H a b e r m a n n , 
H . G. H e i n z e , K . H o r n , C. R. P i c k a r d t , M . R e t t i g a n d T. R u h l 
Duplicate determinations of urinary iodine on two consecutive days were carried out 
on 134 patients from the Munich area. A mean value (± SD) of 36.9 ± 23.7 mcg iodine 
in a 24 hour urine collection was found. 
In patients with non-toxic goiters a disproportionate increase in the secretion of T 3 
over T 4 was found. This may explain the discrepancy between the clinical impression, 
that these patients were euthyroid, and the fact that their thyroxine levels were sig-
nificantly lower than those of normal controls. From the controls (N = 23) we found 
the following values: T 4 - 7 . 6 5 ± 1 . 0 7 mcg/100 ml, T 3 = 1 4 6 ± 2 0 ng/100 ml and 
T 3/T 4 ratio = 19.6 ± 4.1 (ng/mcg). From the patients with non-toxic goiter (N = 43) 
the total T 4 values were significantly lower than normal (6.19 ± 1.42 mcg per 100 ml), 
while the total T 3 values (171 ± 4 1 ng/100 ml) and the T 3/T 4 ratios (28.8 ± 8.9 
ng/mcg) were significantly (P < 0.005) higher { H o r n K . et a l . , Z. klin. Chem. 10 
(1972) 99. 
Patients with non-toxic goiters (N = 49) were administered 200 mcg synthetic 
TRH i. v. In the larger group (N = 38) we have found, that the individual TSH 
response 30 min after TRH injection were within the normal ränge (2.73-23.6 mcU/ml, 
x log = 8.02 mcU/ml). Mean basal TSH levels (3.01 mcU/ml) were not higher than 
normal (x log = 2.81 mcU/ml), whereas the mean TSH response at 30 min (10.40 
mcU/ml) was just significantly higher (P < 0.025) than normal. - The remaining 11 
goiter patients had elevated individual TSH responses. The mean basal TSH level 
(x log = 7.75) and the mean TSH response 30 min after TRH (x log = 32.4 mcU/ml) 
were significantly greater (P < 0.0005) than normal. - The measured levels of T 4-
iodine (CPB-analysis, H o r n K . et a l , Z. anal. Chem. 2 5 9 , 222 (1972)) in both groups of 
patients with nontoxic goiter did not allow the differentiation between the two groups, 
but were both (3.44 and 2.94 mcg/100 ml below the normal value (x log = 4.11 mcg/ 
100 ml, P < 0.005). - In the group of goiter patients with elevated TSH responses 
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we assume, that the compensatory increased secretion of T 3 does not render these 
patients euthyroid (preclinical hypothyroidism). 
The dosage of thyroid hormone therapy for non-toxic goiter patients may effectively 
be controlled by Observation of the TSH suppression before and after T R H Stimulation 
{Pickardt C. R. et al., Klin. Wschr. 50 (1972) in print). 
* Supported by the Deutsche Forschungsgemeinschaft (SFB 51). 
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